The Readout Loud 279: Live from the 2023 STAT Summit
Oct 19, 2023
Live from the 2023 STAT Summit, the hosts discuss genome editing milestones, twists in ALS treatments, and the polarizing process of pronouncing words in biotech. They also explore the potential impact of in vivo gene editing therapy, debates over pronunciation of acronyms and drug names, and the future of neurodegenerative diseases research.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 1min
Recent Developments in Biotech News: In Vivo Gene Editing and Intellia Therapeutics
01:27 • 10min
Pronunciation Debates: GOP one and Sennofi
11:53 • 2min
Pronunciation and Connotations of Drug Names
13:32 • 2min
Pronunciation of NIBR and Mound Jaro
15:05 • 4min
The Future of Neurodegenerative Diseases
18:42 • 15min